Semaglutide Research Vial 5mg

Semaglutide is a synthetic analogue of the human incretin hormone glucagon-like peptide-1 (GLP-1). Developed by Novo Nordisk, this compound features a modified peptide backbone incorporating a fatty acid side chain that enables albumin binding, resulting in an extended pharmacokinetic profile with a half-life of approximately 7 days. This structural modification makes it unique among GLP-1 receptor agonists in terms of duration of action and bioavailability. **Mechanism of Action:** Semaglutide functions as a potent and selective GLP-1 receptor agonist, mimicking the actions of endogenous GLP-1. Activation of GLP-1 receptors in the pancreas potentiates glucose-dependent insulin secretion from pancreatic beta cells while simultaneously suppressing glucagon release from alpha cells. In the gastrointestinal tract, GLP-1 receptor activation slows gastric emptying, contributing to reduced nutrient absorption rates. Central nervous system GLP-1 receptor activation in hypothalamic nuclei reduces appetitive drive and food intake through modulation of orexigenic and anorexigenic signaling pathways. **Research Applications:** With 342 PubMed-indexed studies, semaglutide is among the most extensively documented GLP-1 receptor agonists in the research literature. Key areas of investigation include: studies of energy homeostasis and appetite regulation at the hypothalamic level; metabolic pathway investigations examining glucose-dependent insulin secretion dynamics; cardiovascular outcome research — the SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events (MACE) in study populations; and research into incretin-based signaling cascades. STEP trial data indicates dose-dependent body weight reductions of approximately 15% at the 2.4mg weekly dose over 68-week study periods. **Quality Documentation:** Each vial contains 5mg of semaglutide as a lyophilized powder manufactured under controlled laboratory conditions. Purity is verified at ≥98% by analytical HPLC. Standard reconstitution: add 2mL of bacteriostatic water for a concentration of 2.5mg/mL. Reconstituted solutions maintain stability for up to 28 days when stored at 2-8°C. Batch certificates of analysis are available. This product is intended for laboratory research purposes only and is not for human or veterinary use.